ReviewFrontiers in endocrinology2026
Decoding type 5 diabetes using spatial omics: microarchitectural and molecular mechanisms of malnutrition-associated diabetes.
Review in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This review advocates for the formal recognition of Type 5 Diabetes Mellitus, a distinct, neglected form of non-autoimmune, lean diabetes predominantly affecting low-income and middle-income populations with a history of early-life malnutrition. Characterized by impaired insulin secretion amid preserved insulin sensitivity, this phenotype exhibits unique microarchitectural alterations within pancreatic islets and is strongly linked to malnutrition-induced epigenetic reprogramming and gut microbiota dysbiosis. Recent advancements in spatial omics technologies have illuminated region-specific gene expression, inflammatory pathways, and cellular remodeling in pancreatic tissue, offering novel insights into its pathophysiology. Despite its global prevalence, especially in resource-constrained settings, Type 5 diabetes remains underdiagnosed and poorly understood, hindering the development of tailored diagnostic criteria and therapeutic strategies. This review synthesizes current epidemiological, mechanistic, and molecular evidence, emphasizing the imperative for establishing standardized classification, research collaborations-including the formation of the IDF Type 5 Diabetes Working Group-and region-specific management protocols. Recognizing this disease entity is critical for advancing health equity, improving clinical outcomes, and guiding future research in metabolic disease frameworks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.